| |
The
budget announcements will have a positive impact
on the pharmaceuticals sector. The cut in excise
duty on pharmaceutical products, from 16 per
cent to 8 per cent, will reduce the
burden on players. However, as most large and
mid-sized players have set up manufacturing
facilities in excise-free zones, the overall
impact will be marginal. The 125 per
cent deduction on R&D outsourcing expenditure
will increase the competitiveness of Indian
players. The reduction in customs duty on select
life saving bulk drugs, from 10 per cent to
5 per cent, will be positive. Increase in outlay
for HIV treatment will be positive and will
benefit players such as Cipla, GlaxoSmithKline
and FDC. |
| Pharma
sector along with hospitals are likely to benefit
from increased focus and incentives. |
|
Total allocation to the health sector Rs 16,534
cr. |
| |
| Pharmaceuticals
Industry Challenges |
| |
| •
Generic competition |
| •
Intellectual property protection |
| •
Managing regulatory compliance |
| •
Pricing pressures and shrinking margins |
•
Realising tangible value from strategic alliances,
joint ventures (JVs) and partnering arrangements
|
| •
I.P.R |
| •
Reputation management |
| •
To setup In-House R & D Centre |
| •
Tax Credit on Global R & D |
•
Successfully developing innovative drugs and
enhancing research & development productivity
|
| •
Sustaining growth in global markets |
| |
India,
with an interesting demography that can create
a good environment for biotech companies. The
Indian subcontinent has a varied species of
flora and fauna and it is observed that the
bio-diversity will be an advantage for the biotech
companies to find samples and conduct field
research much more efficiently. |
| |
By
2020 the pharmaceutical market is anticipated
to more than double to $1.3 trillion, with the
E7 countries - Brazil, China, India, Indonesia,
Mexico, Russia and Turkey - accounting around
one fifth of global pharmaceutical sales |
| |
The
Pharmaceutical Industry in India is in the front
rank of India’s science-based industries with
wide ranging capabilities in the complex field
of drug manufacture and technology |
| |
From
simple headache pills to sophisticated antibiotics
and complex biotechnology derived products,
almost every type of medicine is now made in
India. |
| |
Companies
can take advantage of the tremendous prospects
in the pharmaceuticals
and biotech sector combined with big tax benefits,
grants, subsidy offered by the Indian government
by setting up an in-house R and D centre. |
|
We
can help you with all the formalities required
to set up in-house r and d centre including
project report, tax saving advise and providing
personnel trained/Scientist in biotechnology. |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
